vimarsana.com

Latest Breaking News On - டாரோ மருந்து தொழில்கள் லிமிடெட் - Page 1 : vimarsana.com

Global $12 37 Billion Cough and Cold Preparations Markets Analysis & Forecasts, 2015-2020, 2020-2025F, 2030F

Global $12 37 Billion Cough and Cold Preparations Markets Analysis & Forecasts, 2015-2020, 2020-2025F, 2030F
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Global $12 37 Billion Cough and Cold Preparations Markets Analysis & Forecasts, 2015-2020, 2020-2025F, 2030F

Global $12 37 Billion Cough and Cold Preparations Markets Analysis & Forecasts, 2015-2020, 2020-2025F, 2030F
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Taro: Fiscal Q1 Earnings Snapshot

Taro: Fiscal Q1 Earnings Snapshot July 27, 2021 FacebookTwitterEmail HAIFA BAY, Israel (AP) Taro Pharmaceutical Industries Ltd. (TARO) on Tuesday reported a loss of $18.8 million in its fiscal first quarter. On a per-share basis, the Haifa Bay, Israel-based company said it had a loss of 50 cents. Earnings, adjusted for non-recurring costs, came to $1.09 per share. The drug maker posted revenue of $147.1 million in the period. Taro shares have fallen nearly 4% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $70.74, an increase of nearly 9% in the last 12 months. This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TARO at https://www.zacks.com/ap/TARO

Taro Announces Resignation of Chief Financial Officer

Taro Announces Resignation of Chief Financial Officer Search jobs Taro Announces Resignation of Chief Financial Officer HAWTHORNE, N.Y. (BUSINESS WIRE) Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) announced today that it has accepted the resignation of its Chief Financial Officer, Daphne Huang, effective August 6, 2021. Ms. Huang is leaving the Company in order to pursue other opportunities. Mr. Uday Baldota, Taro’s CEO, stated, “On behalf of the Company, I want to thank Daphne for her valuable contributions including her efforts over the past year during the COVID-19 pandemic. We wish her the best in her future endeavors.”

A Peek Into The Markets: US Stock Futures Mixed Ahead Of Earnings, Economic Data

A Peek Into The Markets: US Stock Futures Mixed Ahead Of Earnings, Economic Data
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.